Polyamines and IBD progression study
Part of Digestive system clinical trials.
This study looks at how certain natural chemicals called polyamines relate to the activity of inflammatory bowel disease (IBD). It aims to understand if these chemicals can help predict disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with IBD (Crohn’s disease or ulcerative colitis) according to Chinese guidelines.
- You have complete medical records available and are willing to sign a consent form.
- You do not have other serious health conditions like cancer, severe organ problems, or blood disorders.
- You have not had the flu, bacterial dysentery, or other infections in the last 2 weeks.
- You have not taken antibiotics or probiotics in the last 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacteria in your gut that may produce chemicals linked to ongoing pain in Crohn's disease or ulcerative colitis, even when the disease itself is not very active. Researchers want to understand why some people still have moderate to severe abdominal pain even after their inflammation has calmed down.
This study tests a new care program designed to help people with inflammatory bowel disease (IBD) manage their condition better and improve their quality of life. If you join, you'll receive extra support and training to help you cope with your symptoms and daily life.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study looks at how fats in your blood and gut lining change in inflammatory bowel disease (IBD). It might help doctors understand IBD better and could lead to better treatments.
This study checks how well the anal area works in people with inflammatory bowel disease (IBD), even when your bowel disease is “in remission” but you may still have symptoms. It may help doctors better understand the cause of ongoing problems and guide future care.
Hear when a new Infliximab trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.